Proactive Investors - Run By Investors For Investors

Polarean has submission for US approval and completion of trials 'clearly in its sights'

Richard Hullihen, CEO of Polarean Imaging PLC (LON:POLX), brings Proactive London's Andrew Scott up to date on developments since their IPO back in March.

The company's recently raised US$4mln to complete their clinical trials and submit an NDA for the FDA.

''We're very happy to now have that clearly in our sights and a straight run through to completion on the trials'', Hullihen says.

 
Meet Rockfire Resources PLC, Touchstone Exploration Inc, Mkango Resources Ltd and Salt Lake Potash Ltd at our event, London , 20 June 2019. Register here »
View full POLX profile View Profile

Polarean Imaging PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use